Wall Street Analysts See a 44.84% Upside in ANI (ANIP): Can the Stock Really Move This High?Zacks Investment Research • 03/12/26
ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/11/26
ANI (ANIP) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/27/26
ANI Pharmaceuticals (ANIP) Surpasses Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/27/26
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial GuidanceGlobeNewsWire • 02/27/26
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 02/20/26
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ETGlobeNewsWire • 02/13/26
ANI Pharmaceuticals, Inc. (ANIP) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
Strength Seen in ANI (ANIP): Can Its 10.6% Jump Turn into More Strength?Zacks Investment Research • 01/13/26
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic PrioritiesGlobeNewsWire • 01/12/26
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/06/26
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 12/31/25